Drugs / Indacaterol/Glycopyrronium
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03364829 | Jan 2016 → Apr 2018 | chronic obstructive pulmonary disease | Taipei Medical University Shuang Ho Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Indacaterol/Glycopyrronium | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03364829 ↗ |